Source:http://linkedlifedata.com/resource/chebi/id/CHEBI:5568
Predicate | Object |
---|---|
rdf:type | |
skos:definition |
"An aromatic ether resulting from oxidative dimerisation between the 4-hydroxy group of one molecule of (1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol and the 3-position of the 4-hydroxybenzyl group of another." []
|
skos:inScheme | |
skos:prefLabel |
guattegaumerine
|
skos:altLabel |
(1R)-1-[4-(2-hydroxy-5-{[(1R)-7-hydroxy-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}phenoxy)benzyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol,
Guattegaumerine
|
skos:notation |
Beilstein:1523406 "Beilstein Registry Number",
ChemIDplus:21446-35-5 "CAS Registry Number",
CiteXplore:17405005 "PubMed citation",
CiteXplore:19015976 "PubMed citation",
CiteXplore:3575505 "PubMed citation",
KEGG COMPOUND:C06511 "KEGG COMPOUND",
Reaxys:1523406 "Reaxys Registry Number"
|
skos:broader | |
skos:relatedSynonym |
Dauriciline,
7-Isoquinolinol, 1,2,3,4-tetrahydro-1-((4-(2-hydroxy-5-((1,2,3,4-tetrahydro-7-hydroxy-6-methoxy-2-methyl-1-isoquinolinyl)methyl)phenoxy)phenyl)methyl)-6-methoxy-2-methyl-, (R-(R*,R*))-,
(-)-N,N-dimethyllindoldhamine,
7,7'-Demethyldauricine,
C36H40N2O6,
COc1cc2CCN(C)[C@H](Cc3ccc(Oc4cc(C[C@H]5N(C)CCc6cc(OC)c(O)cc56)ccc4O)cc3)c2cc1O,
InChI=1S/C36H40N2O6/c1-37-13-11-24-18-34(42-3)32(40)20-27(24)29(37)15-22-5-8-26(9-6-22)44-36-17-23(7-10-31(36)39)16-30-28-21-33(41)35(43-4)19-25(28)12-14-38(30)2/h5-10,17-21,29-30,39-41H,11-16H2,1-4H3/t29-,30-/m1/s1,
InChIKey=FDABVSXGAMFQQH-LOYHVIPDSA-N
|